Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedNew related topics were added to the page (Multiple myeloma; MedlinePlus Genetics), and the revision tag was updated from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check14 days agoChange DetectedA new page revision label 'Revision: v3.6.2' was added. References to 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.0' were removed, indicating a minor backend/text cleanup.SummaryDifference0.2%

- Check21 days agoChange DetectedMultiple myeloma is added as a related topic in the MedlinePlus Genetics section of the page. This enriches contextual information but does not change the study's content or functionality.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now includes the investigator’s name and new help links (How to Read a Study Record, Common Questions, How to Join a Study) plus a revision note (Revision: v3.6.0); at the same time, several legacy elements such as status labels, the 'Intervention / Treatment' header, and some topic references were removed.SummaryDifference2%

- Check35 days agoChange DetectedMetadata now lists Last known status details, the contributor and affiliation, and the new revision tag Revision: v3.5.5. The previous revision label Revision: v3.5.4 was removed.SummaryDifference0.5%

- Check49 days agoChange DetectedThe study page now includes related-topic navigation links for Multiple Myeloma and MedlinePlus Genetics, providing quick access to background information and genetics resources.SummaryDifference0.2%

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.